OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Improving these processes involves adjusting various parameters, including cell line development, media formulation, and bioreactor environments. A key goal is to amplify antibody production while minimizing productio